Laila Catalina Roisman

5PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 18, 2025
Amivantamab as a salvage therapy post-EGFR-tyrosine kinase inhibitor failure in patients with mutated EGFR non-small cell lung cancer.

Bilal Krayim, Waleed Kian, Maria Spector

|Mar 30, 2024
Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.

Vered Fuchs, Ariel Sobarzo, Maha Msamra

|Nov 22, 2023
Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer.

Laila C Roisman, Waleed Kian, Alaa Anoze

|Nov 16, 2020
Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases.

Iris M Goldstein, Laila C Roisman, Shoshana Keren-Rosenberg

Pageof 1